RedCloud Bio
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Phase I/IIa Study of H002 in NSCLC With Active EGFR Mutation (NCT05519293) | RedCloud Bio | 2022-12-15 |
| H002 in Patients With EGFR Mutation Locally Advanced or Metastatic NSCLC (NCT05552781) | RedCloud Bio | 2022-08-26 |
Track RedCloud Bio automatically
Every clearance here is in the API, with alerts when new ones post.